Carrie A. Thompson

7.3k total citations
183 papers, 2.9k citations indexed

About

Carrie A. Thompson is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Carrie A. Thompson has authored 183 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Pathology and Forensic Medicine, 64 papers in Oncology and 45 papers in Genetics. Recurrent topics in Carrie A. Thompson's work include Lymphoma Diagnosis and Treatment (92 papers), Chronic Lymphocytic Leukemia Research (37 papers) and CNS Lymphoma Diagnosis and Treatment (25 papers). Carrie A. Thompson is often cited by papers focused on Lymphoma Diagnosis and Treatment (92 papers), Chronic Lymphocytic Leukemia Research (37 papers) and CNS Lymphoma Diagnosis and Treatment (25 papers). Carrie A. Thompson collaborates with scholars based in United States, France and Belarus. Carrie A. Thompson's co-authors include Thomas M. Habermann, James R. Cerhan, David J. Inwards, Thomas E. Witzig, Grzegorz S. Nowakowski, Stephen M. Ansell, Matthew J. Maurer, Ivana N. Micallef, William R. Macon and Patrick B. Johnston and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Carrie A. Thompson

166 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carrie A. Thompson United States	28	1.4k	1.4k	631	409	285	183	2.9k
Russell Patmore United Kingdom	26	1.7k 1.2×	1.6k 1.1×	991 1.6×	355 0.9×	285 1.0×	71	3.3k
Sandra Eloranta Sweden	31	635 0.4×	957 0.7×	638 1.0×	146 0.4×	133 0.5×	125	3.1k
Benjamin Kasenda Switzerland	25	570 0.4×	564 0.4×	465 0.7×	564 1.4×	189 0.7×	64	1.9k
Gerard Vreugdenhil Netherlands	40	660 0.5×	3.2k 2.2×	458 0.7×	162 0.4×	219 0.8×	165	5.0k
Laura Giordano Italy	31	519 0.4×	982 0.7×	153 0.2×	341 0.8×	161 0.6×	165	3.3k
María A. López-Olivo United States	34	339 0.2×	974 0.7×	421 0.7×	130 0.3×	587 2.1×	134	4.4k
James D. Bearden United States	31	452 0.3×	1.7k 1.2×	267 0.4×	101 0.2×	134 0.5×	94	3.1k
Nils Feltelius Sweden	32	1.0k 0.7×	439 0.3×	736 1.2×	148 0.4×	822 2.9×	79	4.1k
Giovanni Rosti Italy	29	228 0.2×	804 0.6×	298 0.5×	504 1.2×	161 0.6×	127	2.7k
Emanuele Crocetti Italy	36	404 0.3×	2.6k 1.8×	214 0.3×	141 0.3×	167 0.6×	202	4.4k

Countries citing papers authored by Carrie A. Thompson

Since Specialization

Citations

This map shows the geographic impact of Carrie A. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carrie A. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carrie A. Thompson more than expected).

Fields of papers citing papers by Carrie A. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carrie A. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carrie A. Thompson. The network helps show where Carrie A. Thompson may publish in the future.

Co-authorship network of co-authors of Carrie A. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Carrie A. Thompson. A scholar is included among the top collaborators of Carrie A. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carrie A. Thompson. Carrie A. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Link, Brian K., Matthew J. Maurer, Melissa C. Larson, et al.. (2024). Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature. Blood Advances. 8(23). 5939–5948. 2 indexed citations

Pophali, Priyanka A., Lindsay M. Morton, Susan K. Parsons, et al.. (2023). Critical gaps in understanding treatment outcomes in adolescents and young adults with lymphoma: A review of current data. SHILAP Revista de lepidopterología. 4(4). 927–933. 2 indexed citations

Linton, Kim, Lena Specht, Astrid Pavlovsky, et al.. (2023). Personalised therapy in follicular lymphoma – is the dial turning?. Hematological Oncology. 42(6). e3205–e3205. 4 indexed citations

Strouse, Christopher, Melissa C. Larson, Shawna L. Ehlers, et al.. (2022). Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis. JCO Oncology Practice. 18(7). e1069–e1080. 2 indexed citations

Sidana, Surbhi, Cristine Allmer, Melissa C. Larson, et al.. (2022). Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard Care. JCO Oncology Practice. 18(8). e1320–e1333. 6 indexed citations

Mwangi, Raphael, Rebecca L. King, Matthew J. Maurer, et al.. (2022). Increasing tissue requirements in lymphoma trials may exclude patients with high-risk disease or worse prognosis. Blood Advances. 6(24). 6180–6186. 1 indexed citations

Thompson, Carrie A., et al.. (2022). A Retrospective Evaluation of a Nurse Practitioner-Led Cancer Genetics Program. The Journal for Nurse Practitioners. 18(3). 276–284. 3 indexed citations

Tun, Aung M., Arushi Khurana, Raphael Mwangi, et al.. (2022). Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study. Blood Advances. 6(17). 5210–5221. 7 indexed citations

Boddicker, Nicholas, Melissa C. Larson, Alessia Castellino, et al.. (2021). Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era. American Journal of Hematology. 96(8). 979–988. 10 indexed citations

10.

Wang, Yucai, Matthew J. Maurer, Melissa C. Larson, et al.. (2019). Impact of metformin use on the outcomes of newly diagnosed diffuse large B‐cell lymphoma and follicular lymphoma. British Journal of Haematology. 186(6). 820–828. 17 indexed citations

11.

Thompson, Carrie A., et al.. (2019). TIPs as Texts: Community College Students' Perceptions of Open Educational Resources.. International journal on teaching and learning in higher education. 31(2). 238–248. 2 indexed citations

12.

Marshall, Ariela L., Ruchi Gupta, Diane E. Grill, et al.. (2018). Identification of Factors Associated with Hematology-Oncology Fellow Academic Success and Career Choice. Journal of Cancer Education. 34(6). 1219–1224. 8 indexed citations

13.

Kleinstern, Geffen, Matthew J. Maurer, Mark Liebow, et al.. (2018). History of autoimmune conditions and lymphoma prognosis. Blood Cancer Journal. 8(8). 73–73. 24 indexed citations

14.

Wang, Yucai, Yanru Wang, Gita Thanarajasingam, et al.. (2017). Second Primary Malignancies in Patients with Non-Hodgkin Lymphoma. Blood. 130. 2152–2152. 1 indexed citations

15.

Asiedu, Gladys B., et al.. (2017). Building a Healthy Body After Cancer: Young Adult Lymphoma Survivors' Perspectives on Exercise After Cancer Treatment. Journal of Adolescent and Young Adult Oncology. 7(2). 217–229. 5 indexed citations

16.

Ruddy, Kathryn J., Holly K. Van Houten, Lindsey R. Sangaralingham, et al.. (2017). Impact of treatment regimen on acute care use during and after adjuvant chemotherapy for early-stage breast cancer. Breast Cancer Research and Treatment. 164(3). 515–525. 8 indexed citations

17.

Cutshall, Susanne M., S. Stephen, Daniela Stan, et al.. (2015). Symptom burden and integrative medicine in cancer survivorship. Supportive Care in Cancer. 23(10). 2989–2994. 23 indexed citations

18.

Nowakowski, Grzegorz S., Betsy LaPlant, William R. Macon, et al.. (2014). Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study. Journal of Clinical Oncology. 33(3). 251–257. 268 indexed citations

19.

Thompson, Carrie A., Robert A. Kyle, Morie A. Gertz, et al.. (2009). Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients. American Journal of Hematology. 85(3). 171–173. 54 indexed citations

20.

Hoyt, Jeff E., et al.. (2008). Assessing Part-Time Faculty Job Satisfaction in Continuing Higher Education: Implications for the Profession. The Journal of Continuing Higher Education. 56(1). 27–38. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact